You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tafluprost

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Milano, Italy
  • +2 more
Mar 18, 2022

Glaucoma, Ocular Surface Disease Trial (tafluprost, tafluprost and dorzolamide/timolol)

Completed
  • Glaucoma
  • Ocular Surface Disease
  • tafluprost
  • tafluprost and dorzolamide/timolol
  • (no location specified)
Dec 16, 2020

Glaucoma, Primary Open Angle Trial in Tainan (Latanoprost, tafluprost)

Completed
  • Glaucoma, Primary Open Angle
  • Tainan, Taiwan
    Chi Mei Hospital Liouying Branch
Feb 3, 2021

Glaucoma, Open-Angle Trial in Thessaloníki (Tafluprost/timolol fixed combination)

Completed
  • Glaucoma, Open-Angle
  • Tafluprost/timolol fixed combination
  • Thessaloníki, Makedonia, Greece
    1st University Department of Ophthalmology
Dec 16, 2020

Glaucoma, Primary Open Angle Glaucoma, Ocular Hypertension Trial in Petaling Jaya (preservative free tafluprost 0.0015%)

Completed
  • Glaucoma
  • +2 more
  • preservative free tafluprost 0.0015%
  • Petaling Jaya, Selangor Darul Ehsan, Malaysia
    THONEH
Dec 1, 2020

Glaucoma Trial in Alexandria (Preservative-free tafluprost eye drops)

Completed
  • Glaucoma
  • Preservative-free tafluprost eye drops
  • Alexandria, Egypt
    Alexandria Faculty of Medicine
Jun 29, 2020

Latanoprost , Travoprost and Tafluprost in Reducing IOP

Completed
  • Primary Open Angle Glaucoma
  • Latanoprost 0.005% Ophthalmic Solution
  • +2 more
  • Cairo, Egypt
    Kasr El-Aini hospital
Jul 3, 2020

Open-angle Glaucoma, Ocular Hypertension Trial in Changsha, Shanghai (A preservative-free, a clear, colorless sterile aqueous

Unknown status
  • Open-angle Glaucoma, Ocular Hypertension
  • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL
  • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost in 1mL
  • Changsha, China
  • +1 more
Jun 16, 2020

Open Angle Glaucoma and Cataract Trial in Norwich (Prostaglandins)

Completed
  • Open Angle Glaucoma and Cataract
  • Norwich, Norfolk, United Kingdom
    Norfolk & Norwich University Hospitals NHS Foundation Trust
Oct 7, 2020

Glaucoma, Ocular Surface Disease Trial in Thessaloniki (Assessment of ocular surface staining (Oxford score 0-15 scale), mean

Completed
  • Glaucoma
  • Ocular Surface Disease
  • Assessment of ocular surface staining (Oxford score 0-15 scale)
  • mean diurnal intraocular pressure-lowering
  • Thessaloniki, Greece
    University Department of Ophthalmology
Dec 16, 2020

Glaucoma, Ocular Hypertension Trial (Preservative-Free Tafluprost or vehicle, Preservative-Free Timolol maleate)

Completed
Has Results
  • Glaucoma
  • Ocular Hypertension
  • Preservative-Free Tafluprost or vehicle
  • Preservative-Free Timolol maleate
  • (no location specified)
Aug 21, 2018

Glaucoma; Drugs Trial (tafluprostin)

Unknown status
  • Glaucoma; Drugs
  • (no location specified)
Jul 19, 2018

Glaucoma Trial in Goiânia (Trabeculectomy surgery)

Completed
  • Glaucoma
  • Trabeculectomy surgery
  • Goiânia, Goias, Brazil
    Centro de Referencia em Oftalmologia
Aug 17, 2023

Ocular Surface in Primary Open Angle Glaucoma or Ocular

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
    • Valladolid, Spain
      IOBA
    Jan 28, 2022

    Coronary Artery Disease, Glaucoma Trial (Genetic risk assessment)

    Not yet recruiting
    • Coronary Artery Disease
    • Glaucoma
    • Genetic risk assessment
    • (no location specified)
    Dec 13, 2021

    Ocular Surface Disease in Malaysian Glaucoma Patients

    Unknown status
    • Primary Open-angle Glaucoma
    • +4 more
      • (no location specified)
      Oct 25, 2020

      Glaucoma and Ocular Hypertension Trial in United States (DE-117, 0.0015% tafluprost, DE-117 and 0.0015% tafluprost)

      Completed
      • Glaucoma and Ocular Hypertension
      • Newport Beach, California
      • +9 more
      Apr 16, 2018

      Thyroid Eye Disease, Ocular Hypertension, Glaucoma Trial in Stanford (Prostaglandin Analog, Timolol)

      Withdrawn
      • Thyroid Eye Disease
      • +2 more
      • Stanford, California
        Stanford Hospital and Clinics
      May 14, 2018

      Glaucoma, Ocular Hypertension Trial in Philadelphia, London (Preservative free tafluprost opthalmic solution)

      Completed
      • Glaucoma
      • Ocular Hypertension
      • Preservative free tafluprost opthalmic solution
      • Philadelphia, Pennsylvania
      • +1 more
      Oct 9, 2017

      Glaucoma, Open-Angle, Ocular Hypertension Trial in Vienna (Tafluprost 15µg/ml)

      Completed
      • Glaucoma, Open-Angle
      • Ocular Hypertension
      • Tafluprost 15µg/ml
      • Vienna, Austria
        Ordination Dr. Hommer
      Aug 22, 2017

      Open-angle Glaucoma, Ocular Hypertension Trial (Preservative-Free Tafluprost, Comparator: timolol)

      Completed
      Has Results
      • Open-angle Glaucoma
      • Ocular Hypertension
      • Preservative-Free Tafluprost
      • Comparator: timolol
      • (no location specified)
      May 29, 2017

      Primary Open-angle Glaucoma Trial (Benzalkonium chloride (BAK), 0.0015% tafluprost)

      Completed
      • Primary Open-angle Glaucoma
      • Benzalkonium chloride (BAK)
      • 0.0015% tafluprost
      • (no location specified)
      Apr 1, 2017

      Glaucoma Trial in Seoul (Xalost S, Xalatan, Taflotan-S)

      Unknown status
      • Glaucoma
      • Xalost S
      • +2 more
      • Seoul, Korea, Republic of
        Taejoon Pharmaceutical Co., Ltd.
      Nov 14, 2019

      Ocular Hypertension, Glaucoma Trial in Worldwide (Preserved Bimatoprost 0.01%, Tafluprost Unit Dose Preservative Free

      Unknown status
      • Ocular Hypertension
      • Glaucoma
      • Preserved Bimatoprost 0.01%
      • Tafluprost Unit Dose Preservative Free 15microgram/ml
      • Vienna, Austria
      • +6 more
      May 11, 2016